Search results for "Symptom onset"

showing 8 items of 8 documents

Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey

2018

Abstract Background The Icatibant Outcome Survey (IOS; NCT01034969) is a Shire‐sponsored, international, observational study monitoring the safety and effectiveness of icatibant, a bradykinin B2 receptor antagonist approved for the acute treatment of adults with hereditary angioedema with C1 inhibitor deficiency (HAE‐C1‐INH). Objective To report IOS data comparing demographic and icatibant treatment outcomes in patients with HAE‐C1‐INH from Germany to HAE‐C1‐INH patients from 11 other IOS countries. Methods A descriptive, retrospective, comparative analysis of data from 685 IOS patients with HAE‐C1‐INH from seven centres in Germany (n = 93) vs. centres from Austria, Brazil, Czech Republic, …

0301 basic medicineAdultMalePediatricsmedicine.medical_specialtyTime FactorsC1 inhibitor deficiencyTime to treatmentDermatologyBradykininAutoimmune DiseasesTime-to-Treatment03 medical and health scienceschemistry.chemical_compound0302 clinical medicineIcatibantGermanyBradykinin B2 Receptor AntagonistsmedicineHumansIn patientSymptom onsetRetrospective Studiesbusiness.industryAngioedemas HereditaryMiddle Agedmedicine.diseaseSymptom Flare UpHealth Surveys030104 developmental biologyInfectious Diseases030228 respiratory systemchemistryHereditary angioedemaObservational studyOriginal ArticleFemaleOutcome databusinessJournal of the European Academy of Dermatology and Venereology
researchProduct

MRS SHOWS ABNORMALITIES BEFORE SYMPTOMS IN FAMILIAL ALZHEIMER DISEASE

2006

Background: Pathologic change in Alzheimer disease (AD) begins some years before symptoms. MRS has the potential to detect metabolic abnormalities reflecting this early pathologic change. Presenilin 1 (PS1) and amyloid precursor protein (APP) mutation carriers have a nearly 100% risk of developing AD and may be studied prior to symptom onset. Methods: Short echo time proton MR spectra were acquired from a midline posterior cingulate voxel in presymptomatic carriers of PS1 or APP mutations (“presymptomatic mutation carriers” [PMCs]; n = 7) and age- and sex-matched control subjects (n = 6). Ratios of N-acetyl aspartate (NAA), myo-inositol (MI), and choline-containing compounds (Cho) to creati…

AdultMalemedicine.medical_specialtyPathologyMagnetic Resonance SpectroscopyAlzheimer disease brain metabolism nuclear magnetic resonance spectroscopyAdolescentNeuropsychological TestsCreatineGastroenterologyPresenilinCentral nervous system diseasechemistry.chemical_compoundDegenerative diseaseAlzheimer DiseaseReference ValuesInternal medicinemental disordersmedicineHumansFamilySymptom onsetAge of OnsetChildSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaBrainInfantMiddle Agedmedicine.diseaseControl subjectsnervous system diseasesnervous systemchemistryChild PreschoolCarrier StateFemaleNeurology (clinical)Alzheimer's diseaseGeometric meanPsychology
researchProduct

Adult polyglucosan body myopathy.

1992

This report describes a sporadic late-onset myopathy in two unrelated adults which was marked by polyglucosan inclusions surrounded by abnormally structured mitochondria, the latter finding a localized, possibly reactive phenomenon. The polyglucosan material was characterized by a battery of histochemical and enzyme histochemical techniques; revealed common antigenicity with Lafora bodies, corpora amylacea and muscle fiber inclusions in types IV and VII glycogenoses; and contained ubiquitin. Additional lectin histochemical and associated digestion preparations disclosed the presence of alpha-glycosyl residues as apparently the sole carbohydrate component in polyglucosan bodies while the abo…

MaleAntigenicityPathologymedicine.medical_specialtyMolecular Sequence DataCarbohydratesPathology and Forensic MedicineCellular and Molecular NeuroscienceUbiquitinMuscular DiseasesPolysaccharidesLectinsmedicineHumansSymptom onsetMuscle fibreMyopathyLafora bodyInclusion BodiesbiologyMusclesLectinGeneral MedicineHypertrophyMiddle AgedMitochondria MuscleMicroscopy ElectronNeurologyBiochemistryCarbohydrate Sequencebiology.proteinFemaleNeurology (clinical)medicine.symptomAtrophyCorpora amylaceaJournal of neuropathology and experimental neurology
researchProduct

Thalamic relay or cortico-thalamic processing? Old question, new answers.

2013

Ascending and descending information is relayed through the thalamus via strong, “driver” pathways. According to our current knowledge, different driver pathways are organized in parallel streams and do not interact at the thalamic level. Using an electron microscopic approach combined with optogenetics and in vivo physiology, we examined whether driver inputs arising from different sources can interact at single thalamocortical cells in the rodent somatosensory thalamus (nucleus posterior, POm). Both the anatomical and the physiological data demonstrated that ascending driver inputs from the brainstem and descending driver inputs from cortical layer 5 pyramidal neurons converge and interac…

MaleCognitive Neuroscienceposterior-medial nucleussupralinearThalamusSensory systemrelaylaw.inventionlayer 5BsomatosensoryCellular and Molecular NeuroscienceThalamusRelaylawNeural PathwaysmedicineAnimalstop–down processingtrigeminalSymptom onsetCerebral CortexNeuronsArticlesmedicine.anatomical_structureCerebral cortexThalamic structureSynapsesPsychologyNeuroscienceCerebral cortex (New York, N.Y. : 1991)
researchProduct

Analysis of the diagnostic pathway and delay in patients with amyotrophic lateral sclerosis in the Valencian Community

2021

Introduction: Amyotrophic lateral sclerosis (ALS) is an insidious, clinically heterogeneous neurodegenerative disease associated with a diagnostic delay of approximately 12 months. No study conducted to date has analysed the diagnostic pathway in Spain. Methods: We gathered data on variables related to the diagnostic pathway and delay for patients diagnosed with ALS between October 2013 and July 2017. Results: The study included 143 patients with ALS (57% men; 68% spinal onset). Patients were diagnosed in public centres in 86% of cases and in private centres in 14%. The mean diagnostic delay was 13.1 months (median 11.7). Patients were examined by neurologists a mean time of 7.9 months afte…

MalePediatricsmedicine.medical_specialtyDelayed DiagnosisDiseaseValencian communityTrayecto diagnósticomedicineHumansIn patientSymptom onsetNeurologistsAmyotrophic lateral sclerosisRC346-429Referral and Consultationbusiness.industryAmyotrophic lateral sclerosis Diagnostic delay Diagnostic pathway Electrophysiological study Esclerosis lateral amiotrófica Estudio electrofisiológico Retraso diagnóstico Trayecto diagnósticoAmyotrophic Lateral SclerosisNeurodegenerative Diseasesmedicine.diseaseRetraso diagnósticoEstudio electrofisiológicoPrivate healthcareFemaleEsclerosis lateral amiotróficaNeurology. Diseases of the nervous systembusinessHealthcare systemEarly referralNeurología (English Edition)
researchProduct

Age at symptom onset, diagnosis, and enzyme replacement therapy (ERT) initiation among family members with mucopolysaccharidosis II (Hunter Syndrome)…

2013

Pediatricsmedicine.medical_specialtyMucopolysaccharidosis IIbusiness.industryEndocrinology Diabetes and MetabolismHunter syndromeEnzyme replacement therapymedicine.diseaseBiochemistrySurgeryEndocrinologyGeneticsmedicineSymptom onsetbusinessMolecular BiologyMolecular Genetics and Metabolism
researchProduct

Hospital Admissions for Acute Myocardial Infarction Before and After Lockdown According to Regional Prevalence of COVID-19 and Patient Profile

2020

Aim: to evaluate the impact of a nationwide lockdown in France on acute myocardial infarction (AMI) admissions, by patient characteristics and regional prevalence of the pandemic. Methods and Results: We collected data from 21 centres participating in the on-going FRENCHIE registry (NCT04050956), which collects data from all patients admitted for STEMI or NSTEMI within 48 hours of symptom onset. We compared weekly admissions in the 4 weeks preceding and the 4 weeks following institution of the lockdown. We observed a brutal 30% decrease in AMI admissions (24% for STEMI and 36% for NSTEMI, P=0.14) following institution of the lockdown, with similar trends according to gender (30% decrease in…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)business.industryFamily medicineHospital admissionmedicinePatient profilePatient characteristicsIn patientSymptom onsetbusinessRegulatory authoritySSRN Electronic Journal
researchProduct

0139 : Extrahospital troponin measurement before admission for a ST segment elevation myocardial infarction

2016

International audience; Background and aimEarly and reliable triage of patients is of major importance to promote rapid and appropriate treatments of patients with ST segment elevation myocardial infarction (STEMI). Extrahospital troponin measurement is used in primary care setting to help the identification of patients with suspected MI. From a regional survey (RICO), we aimed to investigate the frequence and hospital prognosis of STEMI patients with prehospital troponin (PT) measurement.Methods and resultsProspective study on 799 consecutive patients with STEMI included in RICO from March 2013 – 31 may 2015. Among the 799 patients, 38(5%) were identified with PT, from source files and pat…

medicine.medical_specialtyPrimary care030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineTroponin (PT) measurementmedicineTroponin measurementST segment030212 general & internal medicineMyocardial infarctionSymptom onsetSTEMI patientsProspective cohort studyIntensive care medicineST segment elevation myocardial infarctionbiologybusiness.industrymedicine.diseaseTroponinTriage3. Good health[ SDV.NEU ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Emergency medicinebiology.protein[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]businessCardiology and Cardiovascular MedicineArchives of Cardiovascular Diseases Supplements
researchProduct